ナルコレプシー治療薬の世界市場:疾患種類別、治療種類別...市場調査レポートについてご紹介

【英文タイトル】Narcolepsy Drugs Market by Disease Type (Daytime Extreme Sleepiness, Cataplexia, and Others) and Therapeutics Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition and Scope
3.2. Parent Market Overview
3.3. Key Forces Shaping Narcolepsy Drugs Market

3.3.1. Moderate bargaining power of suppliers
3.3.2. Low bargaining power of buyers
3.3.3. Low threat of new entrants
3.3.4. Moderate threat of substitutes
3.3.5. Moderate intensity of rivalry

3.4. Pricing Analysis

3.4.1. Pricing Analysis, By Region, 2018 & 2025

3.5. Market Evolution
3.6. Value Chain Analysis
3.7. Impact of government regulations on global narcolepsy drugs market
3.8. Patent Analysis

3.8.1. By Region
3.8.2. By Applicant

3.9. Market Dynamics

3.9.1. Drivers

3.9.1.1. Increase in global prevalence of narcolepsy
3.9.1.2. Narcolepsy awareness programs and services
3.9.1.3. Presence of reimbursement policies regarding narcolepsy

3.9.2. Restraints

3.9.2.1. Adverse effects and risks related to narcolepsy drugs
3.9.2.2. Delayed diagnosis or misdiagnosis

3.9.3. Opportunity

3.9.3.1. Untapped markets in the developing countries

CHAPTER 4: NARCOLEPSY DRUGS MARKET, BY DISEASE TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Daytime Extreme Sleepiness

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country

4.3. Cataplexia

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

4.4. Other Disease Type

4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

CHAPTER 5: NARCOLEPSY DRUGS MARKET, BY THERAPEUTIC TYPE

5.1. Overview

5.1.1. Market size and forecast

5.2. Central Nervous System Stimulants

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Tricyclic Antidepressants

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. Sodium Oxybate

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

5.5. Selective Serotonin Reuptake Inhibitor

5.5.1. Market size and forecast
5.5.2. Market analysis, by country

5.6. Other Therapeutic Type

5.6.1. Market size and forecast
5.6.2. Market analysis, by country

CHAPTER 6: NARCOLEPSY DRUGS MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends and opportunities
6.2.2. North America market size and forecast, by disease type
6.2.3. North America market size and forecast, by therapeutic type
6.2.4. North America market size and forecast, by country

6.2.4.1. U.S. market size and forecast, by disease type
6.2.4.2. U.S. market size and forecast, by therapeutic type
6.2.4.3. Canada market size and forecast, by disease type
6.2.4.4. Canada market size and forecast, by therapeutic type
6.2.4.5. Mexico market size and forecast, by disease type
6.2.4.6. Mexico market size and forecast, by therapeutic type

6.3. Europe

6.3.1. Key market trends and opportunities
6.3.2. Europe market size and forecast, by disease type
6.3.3. Europe market size and forecast, by therapeutic type
6.3.4. Europe market size and forecast, by country

6.3.4.1. Germany market size and forecast, by disease type
6.3.4.2. Germany market size and forecast, by therapeutic type
6.3.4.3. France market size and forecast, by disease type
6.3.4.4. France market size and forecast, by therapeutic type
6.3.4.5. UK market size and forecast, by disease type
6.3.4.6. UK market size and forecast, by therapeutic type
6.3.4.7. Italy market size and forecast, by disease type
6.3.4.8. Italy market size and forecast, by therapeutic type
6.3.4.9. Spain market size and forecast, by disease type
6.3.4.10. Spain market size and forecast, by therapeutic type
6.3.4.11. Rest of Europe market size and forecast, by disease type
6.3.4.12. Rest of Europe market size and forecast, by therapeutic type

6.4. Asia-Pacific

6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific market size and forecast, by disease type
6.4.3. Asia-Pacific market size and forecast, by therapeutic type
6.4.4. Asia-Pacific market size and forecast, by country

6.4.4.1. Japan market size and forecast, by disease type
6.4.4.2. Japan market size and forecast, by therapeutic type
6.4.4.3. China market size and forecast, by disease type
6.4.4.4. China market size and forecast, by therapeutic type
6.4.4.5. Australia market size and forecast, by disease type
6.4.4.6. Australia market size and forecast, by therapeutic type
6.4.4.7. India market size and forecast, by disease type
6.4.4.8. India market size and forecast, by therapeutic type
6.4.4.9. South Korea market size and forecast, by disease type
6.4.4.10. South Korea market size and forecast, by therapeutic type
6.4.4.11. Rest of Asia-Pacific market size and forecast, by disease type
6.4.4.12. Rest of Asia-Pacific market size and forecast, by therapeutic type

6.5. LAMEA

6.5.1. Key market trends and opportunities
6.5.2. LAMEA market size and forecast, by disease type
6.5.3. LAMEA market size and forecast, by therapeutic type
6.5.4. LAMEA market size and forecast, by country

6.5.4.1. Brazil market size and forecast, by disease type
6.5.4.2. Brazil market size and forecast, by therapeutic type
6.5.4.3. Saudi market size and forecast, by disease type
6.5.4.4. Saudi market size and forecast, by therapeutic type
6.5.4.5. South Africa market size and forecast, by disease type
6.5.4.6. South Africa market size and forecast, by therapeutic type
6.5.4.7. Rest of LAMEA market size and forecast, by disease type
6.5.4.8. Rest of LAMEA market size and forecast, by therapeutic type

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Market Share Analysis of Top Players, 2018 (%)
7.3. Product Mapping of Top Players
7.4. Competitive Heatmap

CHAPTER 8: COMPANY PROFILES

8.1. ARENA PHARMACEUTICAL, INC.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance

8.2. BIOPROJET PHARMA SARL

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments

8.3. JAZZ PHARMACEUTICAL PLC

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Operating segments
8.3.5. Business Performance
8.3.6. Key strategic moves and developments

8.4. LIGAND PHARMACEUTICALS INCORPORATED

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance

8.5. NOVARTIS INTERNATIONAL AG

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance

8.6. SHINOGI INC.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance

8.7. TAKEDA PHARMACEUTICAL COMPANY

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance

8.8. TEVA PHARMACEUTICAL INDUSTRIES LTD.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance


【レポート販売概要】

■ タイトル:ナルコレプシー治療薬の世界市場:疾患種類別、治療種類別
■ 英文:Narcolepsy Drugs Market by Disease Type (Daytime Extreme Sleepiness, Cataplexia, and Others) and Therapeutics Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日:2019年7月
■ 調査会社:Allied Market Research
■ 商品コード:AMR9NV071
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。